Dr Mainul Haque from the University of Portsmouth’s School of Mathematics and Physics has partnered with Royal Navy intensive Care consultant Timothy Scott to develop a computerised simulator.

The system is intended to facilitate research on treatments for primary blast lung injuries caused by exposure to the supersonic shock waves that radiate from an explosion. Researchers have so far relied on animal testing to assess new therapeutics, but this process is considered slow and costly.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

When a shock wave passes through the body, it can damage multiple internal organs without external signs of injury. There is not currently any protective clothing that can negate the effects and no established therapeutic model for deciding what type of mechanical ventilation or drug treatment will be most effective.

“A computerised model allows us to run as many treatment trials as we need to for any type of scenario quickly.”

Dr Haque said: “A bomb blast greatly increases the air pressure nearby, resulting in a wave of highly pressured air radiating outwards from ground zero.

“Depending on the size and power of the explosion, the resulting shockwaves energise and damage material close by and, in people, the damage is concentrated mostly in the lungs.”

The new simulator model is expected to offer a cost-effective tool to test therapies for at-home and on-the-field treatment of blast lung injury patients.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Scott noted: “A computerised model allows us to run as many treatment trials as we need to for any type of scenario quickly and easily without the need for live animal research.”

The computerised model can simulate complete body systems, including reactions to the excess fluid that accumulates after injury or inflammation.

The system has been validated using the Joint Theatre Trauma Registry, a casualty database from the Afghanistan war, as well as human and animal data sets.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact